19.09.2021

17:21

FDA grants accelerated approval to mobocertinib

FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations

FDA

מן הרשת

19.09.2021

12:04

Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer

The efficacy and safety of trastuzumab deruxtecan (formerly DS-8201), a HER2 antibody–drug conjugate, in patients with HER2-mutant NSCLC have not been investigated extensively

NEJM

מן הרשת

19.09.2021

11:59

חשיבות כאב בקשר בין מחלות כרוניות ודיכאון

במאמר שפורסם בכתב העת BMC Psychiatry מדווחים חוקרים על תוצאות מחקר חדש, מהן עולה כי דרגת הכאב הינה גורם מתווך חשוב בקשר בין מחלות כרוניות ובין דיכאון

BMC Psychiatry

מן הרשת

05.09.2021

10:58

Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer

Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study

Journal of Clinical Oncology

מן הרשת

02.09.2021

14:25

Liquid Biopsy for Advanced NSCLC

A Consensus Statement From the International Association for the Study of Lung Cancer

IASLC

מן הרשת

02.09.2021

14:23

Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade

Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

American Association for Cancer Research

מן הרשת

24.08.2021

15:37

The global burden of skin cancer

A longitudinal analysis from the Global Burden of Disease Study, 1990-2017

JAAD Int

מן הרשת

24.08.2021

15:36

Clinical outcomes in cancer patients with COVID-19

Active cancer patients had worse survival outcomes compared to patients with a history of cancer despite similar COVID-19 disease characteristics

Cancer Rep (Hoboken)

מן הרשת

16.08.2021

16:33

Patients With Metastatic Castration-Resistant Prostate Cancer

Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide

Front. Pharmacol

מן הרשת

08.08.2021

12:56

Amivantamab in EGFR Exon 20 Insertion-Mutated NSCLC Progressing on Platinum Chemotherapy

Initial Results From the CHRYSALIS Phase I Study

Journal of Clinical Oncology

מן הרשת

03.08.2021

16:32

Abemaciclib Combined With Endocrine Therapy

for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Journal of Clinical Oncology

מן הרשת

03.08.2021

16:31

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Poly(adenosine diphosphate–ribose) polymerase inhibitors target cancers with defects in homologous recombination repair by synthetic lethality. New therapies are needed to reduce recurrence in patients with BRCA1 or BRCA2 germline mutation–associated early breast cancer

NEJM

מן הרשת

02.08.2021

17:04

Hospitalization for adverse events under abiraterone or enzalutamide exposure in real-world setting

A French population-based study on prostate cancer patients

British Pharmacological Society

מן הרשת

29.07.2021

11:04

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer

A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC)

Journal of Thoracic Oncology

מן הרשת

25.07.2021

11:31

Efficacy, Safety and Biomarker Analysis of Combined PD-L1 and VEGF

Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

Cancer Discov

מן הרשת

FDA grants accelerated approval to mobocertinib

FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations

Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer

The efficacy and safety of trastuzumab deruxtecan (formerly DS-8201), a HER2 antibody–drug conjugate, in patients with HER2-mutant NSCLC have not been investigated extensively

חשיבות כאב בקשר בין מחלות כרוניות ודיכאון

במאמר שפורסם בכתב העת BMC Psychiatry מדווחים חוקרים על תוצאות מחקר חדש, מהן עולה כי דרגת הכאב הינה גורם מתווך חשוב בקשר בין מחלות כרוניות ובין דיכאון

Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer

Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study

Liquid Biopsy for Advanced NSCLC

A Consensus Statement From the International Association for the Study of Lung Cancer

Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade

Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

The global burden of skin cancer

A longitudinal analysis from the Global Burden of Disease Study, 1990-2017

Clinical outcomes in cancer patients with COVID-19

Active cancer patients had worse survival outcomes compared to patients with a history of cancer despite similar COVID-19 disease characteristics

Patients With Metastatic Castration-Resistant Prostate Cancer

Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide

Amivantamab in EGFR Exon 20 Insertion-Mutated NSCLC Progressing on Platinum Chemotherapy

Initial Results From the CHRYSALIS Phase I Study

Abemaciclib Combined With Endocrine Therapy

for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Poly(adenosine diphosphate–ribose) polymerase inhibitors target cancers with defects in homologous recombination repair by synthetic lethality. New therapies are needed to reduce recurrence in patients with BRCA1 or BRCA2 germline mutation–associated early breast cancer

Hospitalization for adverse events under abiraterone or enzalutamide exposure in real-world setting

A French population-based study on prostate cancer patients

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer

A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC)

Efficacy, Safety and Biomarker Analysis of Combined PD-L1 and VEGF

Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

27.09.2021

מחקרים וחדשות רפואה

תגובות אחרונות

7 הכי נקראות